Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development. - Wikidata - awgldk - TriplyDB

Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development.

Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development.

http://www.wikidata.org/entity/Q44683813

about

TAK1 is a master regulator of epidermal homeostasis involving skin inflammation and apoptosis Membrane trafficking of death receptors: implications on signalling Obesity and cancer: at the crossroads of cellular metabolism and proliferation The changing microbial environment and chronic inflammatory disorders.Inducible cutaneous inflammation reveals a protumorigenic role for keratinocyte CXCR2 in skin carcinogenesis Claudin 1 mediates TNFα-induced gene expression and cell migration in human lung carcinoma cells.Upregulation of Toll-like receptor 2 expression in colorectal cancer infected by human cytomegalovirus.A cytokine-mediated link between innate immunity, inflammation, and cancer.Expression of tumor necrosis factor-alpha-mediated genes predicts recurrence-free survival in lung cancer.B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis.Innate sensing of microbial products promotes wound-induced skin cancer CD44 and HCELL: preventing hematogenous metastasis at step 1.Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy.Chronic inflammation in cancer development.Biopsychological stress factors in BRCA mutation carriers Increased tumor necrosis factor receptor 1 expression in human colorectal adenomas.TNF signaling drives myeloid-derived suppressor cell accumulation.Tumor necrosis factor receptor 1/c-Jun-NH2-kinase signaling promotes human neoplasia.TNF Neutralization Results in the Delay of Transplantable Tumor Growth and Reduced MDSC Accumulation.Tumor immunoediting and immunosculpting pathways to cancer progression.Inflammation: a driving force speeds cancer metastasis Bacterial infection of Smad3/Rag2 double-null mice with transforming growth factor-beta dysregulation as a model for studying inflammation-associated colon cancer.Inflammatory doses of UV may not be necessary for skin carcinogenesis.Low levels of tumor necrosis factor alpha increase tumor growth by inducing an endothelial phenotype of monocytes recruited to the tumor site Genetic deletion of TNFα inhibits ultraviolet radiation-induced development of cutaneous squamous cell carcinomas in PKCε transgenic mice via inhibition of cell survival signals.Review series on helminths, immune modulation and the hygiene hypothesis: the broader implications of the hygiene hypothesis.The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans.Review paper: the role of inflammation in mouse pulmonary neoplasia.The diverse roles of the TNF axis in cancer progression and metastasis.Tumor necrosis factor receptor 2 promotes growth of colorectal cancer via the PI3K/AKT signaling pathway.Inflammation, tumor necrosis factor and Wnt promotion in gastric cancer development.Role of TLR2-dependent inflammation in metastatic progression.Focus on skin cancer association and progression under TNF antagonist therapy.Macrophage-tumor crosstalk: role of TAMR tyrosine kinase receptors and of their ligands.TNF-α signaling in Fanconi anemia.Therapeutic non-toxic doses of TNF induce significant regression in TNFR2-p75 knockdown Lewis lung carcinoma tumor implants.Clinical implications of tumor necrosis factor receptor 2 in breast cancer.TWEAK/Fn14 signaling in tumors.TNF-α/TNFR1 signaling promotes gastric tumorigenesis through induction of Noxo1 and Gna14 in tumor cells.Membrane versus soluble isoforms of TNF-α exert opposing effects on tumor growth and survival of tumor-associated myeloid cells.

P2860

Q24676202-086A83CD-A674-4451-8E71-3AADD659D0DC Q26852802-2CC12A32-9FFD-453A-8464-F5B91898A359 Q27003989-088F6D7C-194C-4D4E-8958-50AEC49330D2 Q33846659-BFFDC843-25E2-4B18-AA0C-74E1D09BA90D Q33858156-4567168F-94A6-4FDC-8B45-39DDD18367E0 Q34295450-CB99D237-943D-4991-AA3B-4C5AE40BE63C Q34582645-79D2331B-283B-42A7-8432-AE90865B2439 Q34625152-898C5BB5-1F65-4632-B568-D4A17783EDE3 Q34790174-893F07B5-2BBE-435B-A335-72DCB6641681 Q35081453-666E2D2B-4ED8-483C-BEE0-C01FD9243051 Q35114271-C92AC027-8A3F-4D0D-A014-3B0C4FBD3F47 Q35376738-031F9D83-E9C0-4892-B360-9FA3A2A613DC Q35582297-08735FF0-4C02-4100-B04D-2F8FBAF999C0 Q35928265-1FE176C3-53EB-4738-B58C-1855E231EA8C Q36067716-F4831E0D-7052-4DC4-B09F-2B8A77DC1A92 Q36316684-513471E6-0FCC-43CA-9726-516938E515EF Q36357903-718CBE91-0E05-4413-9E74-8A87CCA4748C Q36454741-DA7FF1B7-A23D-4C22-9A27-E887256E610C Q36809157-C9483167-EB8B-4D7F-9F11-5D9C4420C9B4 Q36896195-09F18CF3-C523-4FEF-A4D0-B18F03F9B211 Q36986448-58606E19-8013-429C-8C2C-DDE344B56AC5 Q37073835-5470294E-FB8A-4DBF-BB79-4C67F64B3AF6 Q37114132-92D8BE9A-C2CB-49A5-B6C0-8CC4FABBE65E Q37118459-85FBDC32-4A8D-47E1-A9DF-0F1D16B830F0 Q37220240-34D39E11-D265-4C8E-820E-13455134B752 Q37361475-EAB8ACE2-699B-4288-90A5-4D3BD99CC404 Q37363065-4CE3B2F1-D051-4998-8F6E-86C4E5F60BCF Q37379547-17CB1C4C-1ED1-4058-ADC2-BF117D1BF982 Q37474735-D2F04084-BAAA-4095-A266-A121AB4D5342 Q37593982-71644E37-05FF-4A53-AEAD-5E942610B04B Q37725907-26646540-139D-49C9-8DFB-7252611DC123 Q37833132-F615C5EF-AF62-49F2-AD69-4557E6F59EB4 Q37901473-46F738A1-1F2A-41FD-8CE1-3A9776B611F5 Q37955105-887194ED-9DF0-463F-9CCE-DC1CD6E76419 Q38124483-4BA0B361-D7A6-4C5A-91CF-D5144741E764 Q38445760-9FA9655A-B6A4-47AE-AB4F-0E1A73DBA317 Q38633647-68D194F7-87A3-4A9C-98FF-1E8CD98EC299 Q38668064-945F9084-310D-4EA2-B891-21B1B8EF9987 Q39105341-DC57164B-E629-4DC1-8AD8-1034F45A997D Q39147966-47A45087-C038-4CFD-8090-C9756A9EE086

P2860

Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development.

http://www.wikidata.org/entity/Q44683813

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Expression of both TNF-alpha r ...... timal skin tumour development.

@en

Expression of both TNF-alpha r ...... timal skin tumour development.

@nl

type

label

Expression of both TNF-alpha r ...... timal skin tumour development.

@en

Expression of both TNF-alpha r ...... timal skin tumour development.

@nl

prefLabel

Expression of both TNF-alpha r ...... timal skin tumour development.

@en

Expression of both TNF-alpha r ...... timal skin tumour development.

@nl

P1433

Q44683813-3D636127-0995-45E2-9070-472BBB74CDE4

P1476

Q44683813-B1A4D5B6-B9C4-4879-976A-AFA5E91A454F

P2093

Q44683813-0DB090A4-BBFC-4E7D-9668-F3670503ACDE

Q44683813-2A48AC1D-8E95-4B01-90EF-6DDBD98D1E21

Q44683813-356F00C1-336F-460E-8415-F5B8ECF94ADC

Q44683813-4BFED0D8-E2B7-493F-B30E-B46A160A3BC3

Q44683813-FA322133-AF06-405F-B847-30D79CAA1E4E

P2860

Q44683813-016445CC-1052-4B33-9874-BF1A93BF6A66

Q44683813-08E03C02-5081-44CB-8E98-F070F8BF5B13

Q44683813-09167413-0AA2-4D9C-9C01-76851C7E56C7

Q44683813-0BB6665A-6564-44D1-881F-03BE9A2B67E3

Q44683813-0CBA769F-6486-4BD2-9ECB-7398C8A9F3DA

Q44683813-15230966-5A8D-4CF9-8A58-BA7BB5A8E591

Q44683813-157E3779-1D6F-4812-8E91-5CFBE142FF04

Q44683813-2478BF7B-18F5-4775-BFF6-B24F93F0A6D6

Q44683813-388FEF02-B804-4A06-94EF-E1A938F600D4

Q44683813-44FC51EB-CBA9-4343-8231-983DEB663E39

P2888

Q44683813-74419F67-741D-4052-9764-1C26E8041DA7

P304

Q44683813-A5E42E9E-D832-499A-A710-D5909A079F1C

P31

Q44683813-9DCD5169-E8B8-462E-9B69-D292178E6986

P356

Q44683813-E6347518-C6ED-4067-996C-54151F336B77

P407

Q44683813-806A532F-8620-4346-B70C-B541E4440AC9

P433

Q44683813-920E0130-939D-490F-A3B9-12600DB3FB4E

P478

Q44683813-16A9ADDC-7884-42C4-840E-DF178D3CFC4F

P50

Q44683813-E8A33A5A-3B5F-4AAB-A202-224D6E354EF9

P577

Q44683813-D14796FE-BF0B-4BD4-8EAD-9E501EEFC7CF

P5875

Q44683813-C656448D-D3BE-43E4-B461-FB168CE9D4D8

P698

Q44683813-F304D001-D431-43E1-B8CE-1458F3EC5F60

P921

Q44683813-5EEB8AED-BE7C-41D2-B8CC-31CF8B940EF6

P356

P1433

P1476

Expression of both TNF-alpha r ...... timal skin tumour development.

@en

P2093

Caroline H Arnott

http://www.w3.org/2001/XMLSchema#string

Kate A Scott

http://www.w3.org/2001/XMLSchema#string

Richard G Thompson

http://www.w3.org/2001/XMLSchema#string

Robert J Moore

http://www.w3.org/2001/XMLSchema#string

Stephen C Robinson

http://www.w3.org/2001/XMLSchema#string

P2860

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation

The TNF and TNF receptor superfamilies: integrating mammalian biology

The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor

A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells

MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis.

The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis.

A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor.

Jun, the oncoprotein.

P2888

P304

1902-1910

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.ONC.1207317

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Frances R Balkwill

P577

2004-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8971759

http://www.w3.org/2001/XMLSchema#string

P698

14661063

http://www.w3.org/2001/XMLSchema#string

P921